Latest 8-K filings

Daedalus Special Acquisition Corp. has announced a non-binding Letter of Intent with HUBX Yazlm Hizmetleri Anonim irketi for a proposed business combination, aiming to take the consumer AI company public on Nasdaq.

Pyxis Oncology announced updated Phase 1 data for its drug candidate micvotabart pelidotin (MICVO) in head and neck cancer, showing a 36% objective response rate and a 94% disease control rate.

Perma-Pipe International Holdings, Inc. announced robust second quarter 2026 financial results, featuring a 24% year-over-year increase in net sales to $59.6 million and a significant rise in net income.

RXO reports a significant increase in truckload gross profit per load for August, surpassing prior outlook and signaling strong operational execution.

Opus Genetics announced positive low-dose Cohort 1 data from its Phase 1/2 trial of OPGx-BEST1 for BEST1-related retinal diseases, showing clinically meaningful improvements in visual function and structural changes, alongside a favorable safety profile.

Soluna Holdings, Inc. announced its CEO will participate in a panel discussion at the H.C. Wainwright 28th Annual Global Investment Conference.

Incannex Healthcare announces patient dosing in a Phase 2 study for IHL-42X, a U.S. patent grant for the same drug, and a robust cash position of approximately $70 million.

Core & Main announced fiscal 2026 second quarter results, showcasing net sales and Adjusted EBITDA growth, alongside continued record share repurchases and a reaffirmed full-year outlook.

BiomX Inc. announced a one-for-ten reverse stock split and a name change to Tessera Defense and Homeland Security Inc., effective September 9 and September 11, 2026, respectively.

Destination XL Group reported second quarter fiscal 2026 results showing a 3.4% decrease in sales to $111.6 million, but a swing to net income of $2.0 million, driven by a significant tariff refund.

Flotek Industries announced a second increase to its 2026 guidance for total revenue and Adjusted EBITDA, driven by robust international chemistry sales and expanding Data Analytics segment contributions.

SailPoint announced robust fiscal second quarter 2027 financial results, highlighted by a 25% year-over-year increase in Annual Recurring Revenue (ARR) to $1.231 billion and significant growth in SaaS ARR.

Tyra Biosciences announced initial positive results from its Phase 2 SURF302 study of dabogratinib for bladder cancer, identifying a potential optimal dose and demonstrating clinical proof of concept.

Sunbelt Rentals announced record first-quarter results for fiscal 2027, exceeding expectations and leading to an upward revision of its full-year guidance.

Kura Oncology has established a new subsidiary, Caspian Therapeutics, to focus on cardiometabolic diseases, raising $50 million in Series A financing and contributing key assets.

Chewy announced robust second quarter fiscal year 2026 financial results, exceeding expectations with net sales of $3.33 billion and a 6.8% Adjusted EBITDA margin, prompting an upward revision of its full-year guidance.

NovoCure Limited announced the retirement of director Timothy Scannell, effective September 2, 2026, citing his decision to step down after five years of service.

AEye announces a multi-million-dollar contract with Lunar Outpost for its Apollo lidar on a lunar vehicle, alongside new developments in sports analytics and continued momentum in defense, automotive, and trucking sectors.

D-Wave Quantum Inc. has finalized a $100 million award agreement with the U.S. Department of Commerce, issuing shares in exchange for funding, which introduces both opportunities and risks.

Signet Jewelers announced robust second quarter Fiscal 2027 results, including a 2.2% same-store sales increase, operating margin expansion, and a significant raise in full-year adjusted EPS guidance.

Korn Ferry announced first quarter fiscal year 2027 results, showcasing a 7% year-over-year increase in fee revenue to $756.5 million and a 6% rise in net income.

Twenty One Capital, Inc. announced the appointment of David J. Goldschmidt to its Board of Directors and Audit Committee, along with his compensation package.

Independence Realty Trust (IRT) and Centerspace (CSR) announced a definitive merger agreement to combine in an all-stock transaction valued at approximately $8.1 billion, creating a leading middle-market multifamily REIT.

J.Jill announced second quarter fiscal year 2026 results, showing a 0.5% increase in net sales to $154.8 million and raising its full-year outlook.

Avalanche Treasury Corporation announced an increase in its board size and the appointment of Virginia Gambale as a new director, effective September 8, 2026.

Albertsons Companies announced the appointment of Meg Whitman as Executive Chair of its Board of Directors, a move aimed at enhancing strategic leadership and operational execution.

The Chemours Company's September 2026 investor presentation highlights strategic advancements, improved financial performance, and a focus on high-growth end markets, while acknowledging ongoing legacy liabilities.

Sysco Corporation announced reaffirmation of its fiscal 2027 guidance, introduced a $500 million AI-powered efficiency program, and raised its mid-term financial targets for fiscal years 2028 and 2029.

Postal Realty Trust, Inc. has completed the acquisition of a 72-property portfolio leased to the USPS for approximately $27.75 million, funded by cash and operating partnership units.

Artificial Intelligence Technology Solutions' subsidiary, RAD, announced expanding orders for RIO, ROSA, and SARA solutions in early Q3, driven by existing customer and partner relationships, aiming to boost recurring monthly revenue.